<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37138871</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Polymorphisms in the <i>MBL2</i> gene are associated with the plasma levels of MBL and the cytokines IL-6 and TNF-&#x3b1; in severe COVID-19.</ArticleTitle><Pagination><StartPage>1151058</StartPage><MedlinePgn>1151058</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1151058</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1151058</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Mannose-binding lectin (MBL) promotes opsonization, favoring phagocytosis and activation of the complement system in response to different microorganisms, and may influence the synthesis of inflammatory cytokines. This study investigated the association of MBL2 gene polymorphisms with the plasma levels of MBL and inflammatory cytokines in COVID-19.</AbstractText><AbstractText Label="METHODS">Blood samples from 385 individuals (208 with acute COVID-19 and 117 post-COVID-19) were subjected to real-time PCR genotyping. Plasma measurements of MBL and cytokines were performed by enzyme-linked immunosorbent assay and flow cytometry, respectively.</AbstractText><AbstractText Label="RESULTS">The frequencies of the polymorphic MBL2 genotype (OO) and allele (O) were higher in patients with severe COVID-19 (p&lt; 0.05). The polymorphic genotypes (AO and OO) were associated with lower MBL levels (p&lt; 0.05). IL-6 and TNF-&#x3b1; were higher in patients with low MBL and severe COVID-19 (p&lt; 0.05). No association of polymorphisms, MBL levels, or cytokine levels with long COVID was observed.</AbstractText><AbstractText Label="DISCUSSION">The results suggest that, besides MBL2 polymorphisms promoting a reduction in MBL levels and therefore in its function, they may also contribute to the development of a more intense inflammatory process responsible for the severity of COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Queiroz, Santiago, Brito, Pereira, de Brito, Torres, Lopes, Santos, da Costa, de Sarges, Cantanhede, de Brito, da Silva, Leite, Viana, Rodrigues, da Silva, Viana, Chaves, Ver&#xed;ssimo, Carvalho, Henriques, Santos, Nunes, Costa, Amoras, Lima, Cayres-Vallinoto, Brasil-Costa, Quaresma, Falc&#xe3;o, Santos and Vallinoto.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Queiroz</LastName><ForeName>Maria Alice Freitas</ForeName><Initials>MAF</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santiago</LastName><ForeName>Ang&#xe9;lica Menezes</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Virology, Evandro Chagas Institute, Department of Science, Technology, Innovation and Strategic Health Inputs, Ministry of Health of Brazil, Ananindeua, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brito</LastName><ForeName>Wandrey Roberto Dos Santos</ForeName><Initials>WRDS</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Keise Adrielle Santos</ForeName><Initials>KAS</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Brito</LastName><ForeName>William Botelho</ForeName><Initials>WB</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Virology, Evandro Chagas Institute, Department of Science, Technology, Innovation and Strategic Health Inputs, Ministry of Health of Brazil, Ananindeua, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>Maria Karoliny da Silva</ForeName><Initials>MKDS</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopes</LastName><ForeName>Jeferson da Costa</ForeName><Initials>JDC</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dos Santos</LastName><ForeName>Erika Ferreira</ForeName><Initials>EF</Initials><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Costa</LastName><ForeName>Fl&#xe1;via P&#xf3;voa</ForeName><Initials>FP</Initials><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Sarges</LastName><ForeName>Kevin Matheus Lima</ForeName><Initials>KML</Initials><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantanhede</LastName><ForeName>Marcos Henrique Damasceno</ForeName><Initials>MHD</Initials><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Brito</LastName><ForeName>Mioni Thieli Figueiredo Magalh&#xe3;es</ForeName><Initials>MTFM</Initials><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Andr&#xe9;a Luciana Soares</ForeName><Initials>ALS</Initials><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leite</LastName><ForeName>Mauro de Meira</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viana</LastName><ForeName>Maria de Nazar&#xe9; do Socorro de Almeida</ForeName><Initials>MNDSA</Initials><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Fab&#xed;ola Brasil Barbosa</ForeName><Initials>FBB</Initials><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Rosilene</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viana</LastName><ForeName>Giselle Maria Rachid</ForeName><Initials>GMR</Initials><AffiliationInfo><Affiliation>Laboratory of Basic Research in Malaria, Parasitology Section, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Brazilian Ministry of Health, Ananindeua, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaves</LastName><ForeName>T&#xe2;nia do Socorro Souza</ForeName><Initials>TDSS</Initials><AffiliationInfo><Affiliation>Laboratory of Basic Research in Malaria, Parasitology Section, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Brazilian Ministry of Health, Ananindeua, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Institute of Medical Sciences, Federal University of Par&#xe1;, Par&#xe1;, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ver&#xed;ssimo</LastName><ForeName>Adriana de Oliveira Lameira</ForeName><Initials>AOL</Initials><AffiliationInfo><Affiliation>Bel&#xe9;m Adventist Hospital, Bel&#xe9;m, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvalho</LastName><ForeName>Mayara da Silva</ForeName><Initials>MDS</Initials><AffiliationInfo><Affiliation>Bel&#xe9;m Adventist Hospital, Bel&#xe9;m, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henriques</LastName><ForeName>Daniele Freitas</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>Laboratory of Immunology, Section of Virology, Instituto Evandro Chagas, Health and Environment Arbovirology and Hemorrhagic Fevers Section, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Ananindeua, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dos Santos</LastName><ForeName>Carla Pinheiro</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Laboratory of Immunology, Section of Virology, Instituto Evandro Chagas, Health and Environment Arbovirology and Hemorrhagic Fevers Section, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Ananindeua, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nunes</LastName><ForeName>Juliana Abreu Lima</ForeName><Initials>JAL</Initials><AffiliationInfo><Affiliation>Laboratory of Immunology, Section of Virology, Instituto Evandro Chagas, Health and Environment Surveillance Secretariat, Brazilian Ministry of Health, Brazilian Ministry of Health, Ananindeua, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Iran Barros</ForeName><Initials>IB</Initials><AffiliationInfo><Affiliation>Graduate Program in Virology, Evandro Chagas Institute, Department of Science, Technology, Innovation and Strategic Health Inputs, Ministry of Health of Brazil, Ananindeua, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Immunology, Section of Virology, Instituto Evandro Chagas, Health and Environment Surveillance Secretariat, Brazilian Ministry of Health, Brazilian Ministry of Health, Ananindeua, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amoras</LastName><ForeName>Ednelza da Silva Gra&#xe7;a</ForeName><Initials>EDSG</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>Sandra Souza</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cayres-Vallinoto</LastName><ForeName>Izaura Maria Vieira</ForeName><Initials>IMV</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brasil-Costa</LastName><ForeName>Igor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Graduate Program in Virology, Evandro Chagas Institute, Department of Science, Technology, Innovation and Strategic Health Inputs, Ministry of Health of Brazil, Ananindeua, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Immunology, Section of Virology, Instituto Evandro Chagas, Health and Environment Surveillance Secretariat, Brazilian Ministry of Health, Brazilian Ministry of Health, Ananindeua, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quaresma</LastName><ForeName>Juarez Ant&#xf4;nio Sim&#xf5;es</ForeName><Initials>JAS</Initials><AffiliationInfo><Affiliation>Center of Biological and Health Sciences, University of the State of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falc&#xe3;o</LastName><ForeName>Luiz F&#xe1;bio Magno</ForeName><Initials>LFM</Initials><AffiliationInfo><Affiliation>Center of Biological and Health Sciences, University of the State of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dos Santos</LastName><ForeName>Eduardo Jos&#xe9; Melo</ForeName><Initials>EJM</Initials><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallinoto</LastName><ForeName>Antonio Carlos Ros&#xe1;rio</ForeName><Initials>ACR</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037601">Mannose-Binding Lectin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C445619">MBL2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="N">Polymorphism, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037601" MajorTopicYN="Y">Mannose-Binding Lectin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">MBL</Keyword><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">polymorphisms</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>4</Day><Hour>2</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37138871</ArticleId><ArticleId IdType="pmc">PMC10149935</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1151058</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
WHO . WHO global clinical platform for the clinical characterization of COVID-19: Statistical analysis plan (2021). Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Clinical-Analytic-plan-2021.1.</Citation></Reference><Reference><Citation>Teijaro JR. Cytokine storms in infectious diseases. Semin Immunopathol (2017) 39(5):501&#x2013;3. doi:&#xa0;10.1007/s00281-017-0640-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-017-0640-2</ArticleId><ArticleId IdType="pmc">PMC7079934</ArticleId><ArticleId IdType="pubmed">28674818</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SH, Minn D, Kim SW, Kim YK. Inflammatory markers and cytokines in moderate and critical cases of COVID-19. Clin Lab (2021) 67(9). doi:&#xa0;10.7754/Clin.Lab.2021.210142</Citation><ArticleIdList><ArticleId IdType="doi">10.7754/Clin.Lab.2021.210142</ArticleId><ArticleId IdType="pubmed">34542974</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Cao J, Yu Y, Ding J, Eshak ES, Liu K, et al. . Epidemiological characteristics of patients with severe COVID-19 infection in wuhan, China: evidence from a retrospective observational study. Int J Epidemiol (2021) 49(6):1940&#x2013;50. doi:&#xa0;10.1093/ije/dyaa180</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyaa180</ArticleId><ArticleId IdType="pmc">PMC7665537</ArticleId><ArticleId IdType="pubmed">33150437</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva Torres MK, Bichara CDA, de Almeida MNDS, Vallinoto MC, Queiroz MAF, Vallinoto IMVC, et al. . The complexity of SARS-CoV-2 infection and the COVID-19 pandemic. Front Microbiol (2022) 13:789882. doi:&#xa0;10.3389/fmicb.2022.789882</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.789882</ArticleId><ArticleId IdType="pmc">PMC8870622</ArticleId><ArticleId IdType="pubmed">35222327</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E. How and why patients made long covid. Soc Sci Med (2021) 268:113426. doi:&#xa0;10.1016/j.socscimed.2020.113426</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>
Collins FS. NIH Launches new initiative to study &#x201c;Long COVID&#x201d; (2021). Available at: https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-launches-new-initiative-study-long-covid.</Citation></Reference><Reference><Citation>Parums DV, Long COVID. Or post-COVID syndrome, and the global impact on health care. Med Sci Monit (2021) 27:e933446. doi:&#xa0;10.12659/MSM.933446</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.933446</ArticleId><ArticleId IdType="pmc">PMC8194290</ArticleId><ArticleId IdType="pubmed">34092779</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) (2021) 53(10):737&#x2013;54. doi:&#xa0;10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz MAF, Neves PFMD, Lima SS, Lopes JDC, Torres MKDS, Vallinoto IMVC, et al. . Cytokine profiles associated with acute COVID-19 and long COVID syndrome. Front Cell Infect Microbiol (2022) 12:922422. doi:&#xa0;10.3389/fcimb.2022.922422</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.922422</ArticleId><ArticleId IdType="pmc">PMC9279918</ArticleId><ArticleId IdType="pubmed">35846757</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultze JL, Aschenbrenner AC. COVID-19 and the human innate immune system. Cell (2021) 184(7):1671&#x2013;92. doi:&#xa0;10.1016/j.cell.2021.02.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.02.029</ArticleId><ArticleId IdType="pmc">PMC7885626</ArticleId><ArticleId IdType="pubmed">33743212</ArticleId></ArticleIdList></Reference><Reference><Citation>Mistry P, Barmania F, Mellet J, Peta K, Strydom A, Viljoen IM, et al. . SARS-CoV-2 variants, vaccines, and host immunity. Front Immunol (2022) 12:809244. doi:&#xa0;10.3389/fimmu.2021.809244</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.809244</ArticleId><ArticleId IdType="pmc">PMC8761766</ArticleId><ArticleId IdType="pubmed">35046961</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues TS, de S&#xe1; KSG, Ishimoto AY, Becerra A, Oliveira S, Almeida L, et al. . Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med (2021) 218(3):e20201707. doi:&#xa0;10.1084/jem.20201707</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20201707</ArticleId><ArticleId IdType="pmc">PMC7684031</ArticleId><ArticleId IdType="pubmed">33231615</ArticleId></ArticleIdList></Reference><Reference><Citation>Miorin L, Kehrer T, Sanchez-Aparicio MT, Zhang K, Cohen P, Patel RS, et al. . SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling. Proc Natl Acad Sci U.S.A. (2020) 117(45):28344&#x2013;54. doi:&#xa0;10.1073/pnas.2016650117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2016650117</ArticleId><ArticleId IdType="pmc">PMC7668094</ArticleId><ArticleId IdType="pubmed">33097660</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Gupta GS. Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs. Mol Cell Biochem (2021) 476(8):2917&#x2013;42. doi:&#xa0;10.1007/s11010-021-04107-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-021-04107-3</ArticleId><ArticleId IdType="pmc">PMC7981598</ArticleId><ArticleId IdType="pubmed">33745077</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Hu M, Li J, Liu Y, Luo J, Zhang L, et al. . Mannan-binding lectin regulates inflammatory cytokine production, proliferation, and cytotoxicity of human peripheral natural killer cells. Mediators Inflammation (2019) 2019:6738286. doi:&#xa0;10.1155/2019/6738286</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/6738286</ArticleId><ArticleId IdType="pmc">PMC6930792</ArticleId><ArticleId IdType="pubmed">31915415</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y, Ma D, Ming S, Zhang L, Zhou J, Shan G, et al. . Mannan-binding lectin reduces CpG DNA-induced inflammatory cytokine production by human monocytes. Microbiol Immunol (2015) 59(4):231&#x2013;7. doi:&#xa0;10.1111/1348-0421.12245</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1348-0421.12245</ArticleId><ArticleId IdType="pubmed">25664598</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack DL, Read RC, Tenner AJ, Frosch M, Turner MW, Klein NJ. Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to neisseria meningitidis serogroup b. J Infect Dis (2001) 184(9):1152&#x2013;62. doi:&#xa0;10.1086/323803</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/323803</ArticleId><ArticleId IdType="pubmed">11598838</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Zhou J, Ma D, Lu X, Ming S, Shan G, et al. . Mannan binding lectin attenuates double-stranded RNA-mediated TLR3 activation and innate immunity. FEBS Lett (2014) 588(6):866&#x2013;72. doi:&#xa0;10.1016/j.febslet.2014.01.064</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2014.01.064</ArticleId><ArticleId IdType="pubmed">24530528</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali YM, Ferrari M, Lynch NJ, Yaseen S, Dudler T, Gragerov S, et al. . Lectin pathway mediates complement activation by SARS-CoV-2 proteins. Front Immunol (2021) 12:714511. doi:&#xa0;10.3389/fimmu.2021.714511</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.714511</ArticleId><ArticleId IdType="pmc">PMC8287855</ArticleId><ArticleId IdType="pubmed">34290717</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao T, Zhu L, Liu H, Zhang X, Wang T, Fu Y, et al. . Highly pathogenic coronavirus n protein aggravates inflammation by MASP-2-mediated lectin complement pathway overactivation. Signal Transduct Target Ther (2022) 7(1):318. doi:&#xa0;10.1038/s41392-022-01133-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01133-5</ArticleId><ArticleId IdType="pmc">PMC9470675</ArticleId><ArticleId IdType="pubmed">36100602</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis (2003) 37(11):1496&#x2013;505. doi:&#xa0;10.1086/379324</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/379324</ArticleId><ArticleId IdType="pubmed">14614673</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallinoto AC, Menezes-Costa MR, Alves AE, Machado LF, de Azevedo VN, Souza LL, et al. . Mannose-binding lectin gene polymorphism and its impact on human immunodeficiency virus 1 infection. Mol Immunol (2006) 43(9):1358&#x2013;62. doi:&#xa0;10.1016/j.molimm.2005.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2005.09.001</ArticleId><ArticleId IdType="pubmed">16214215</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza Pires-Neto O, da Silva Gra&#xe7;a Amoras E, Queiroz MAF, Demachki S, da Silva Conde SR, Ishak R, et al. . Hepatic TLR4, MBL and CRP gene expression levels are associated with chronic hepatitis c. Infect Genet Evol (2020) 80:104200. doi:&#xa0;10.1016/j.meegid.2020.104200</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2020.104200</ArticleId><ArticleId IdType="pubmed">31962161</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Maria E, Latini A, Borgiani P, Novelli G. Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis. Hum Genomics (2020) 14(1):30. doi:&#xa0;10.1186/s40246-020-00280-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40246-020-00280-6</ArticleId><ArticleId IdType="pmc">PMC7484929</ArticleId><ArticleId IdType="pubmed">32917282</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YC, Jeong BH. Strong correlation between the case fatality rate of COVID-19 and the rs6598045 single nucleotide polymorphism (SNP) of the interferon-induced transmembrane protein 3 (IFITM3) gene at the population-level. Genes (Basel) (2020) 12(1):42. doi:&#xa0;10.3390/genes12010042</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes12010042</ArticleId><ArticleId IdType="pmc">PMC7824003</ArticleId><ArticleId IdType="pubmed">33396837</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Huang S, Gao R, Zhou Y, Lai C, Li Z, et al. . Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility. Cell Discovery (2020) 6(1):83. doi:&#xa0;10.1038/s41421-020-00231-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-020-00231-4</ArticleId><ArticleId IdType="pmc">PMC7653987</ArticleId><ArticleId IdType="pubmed">33298875</ArticleId></ArticleIdList></Reference><Reference><Citation>Andolfo I, Russo R, Lasorsa VA, Cantalupo S, Rosato BE, Bonfiglio F, et al. . Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19. iScience (2021) 24(4):102322. doi:&#xa0;10.1016/j.isci.2021.102322</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102322</ArticleId><ArticleId IdType="pmc">PMC7968217</ArticleId><ArticleId IdType="pubmed">33748697</ArticleId></ArticleIdList></Reference><Reference><Citation>Pontes GS, Tameg&#xe3;o-Lopes B, Machado LF, Azevedo VN, Ishak MO, Ishak R, et al. . Characterization of mannose-binding lectin gene polymorphism among human T-cell lymphotropic virus 1 and 2-infected asymptomatic subjects. Hum Immunol (2005) 66:892&#x2013;6. doi:&#xa0;10.1016/j.humimm.2005.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2005.06.006</ArticleId><ArticleId IdType="pubmed">16216673</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y, Liu L, Luo P, Wang A, Jia T, Shen X, et al. . Association between mannose-binding lectin and HIV infection and progression in a Chinese population. Mol Immunol (2009) 47(2-3):632&#x2013;8. doi:&#xa0;10.1016/j.molimm.2009.08.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2009.08.020</ArticleId><ArticleId IdType="pubmed">19796822</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong WP, To YF, Ip WK, Yuen MF, Poon TP, Wong WH, et al. . Mannose-binding lectin in chronic hepatitis b virus infection. Hepatology (2005) 42(5):1037&#x2013;45. doi:&#xa0;10.1002/hep.20891</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.20891</ArticleId><ArticleId IdType="pubmed">16231358</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutsounaki E, Goulielmos GN, Koulentaki M, Choulaki C, Kouroumalis E, Galanakis E. Mannose-binding lectin MBL2 gene polymorphisms and outcome of hepatitis c virus-infected patients. J Clin Immunol (2008) 28(5):495&#x2013;500. doi:&#xa0;10.1007/s10875-008-9201-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-008-9201-8</ArticleId><ArticleId IdType="pubmed">18592362</ArticleId></ArticleIdList></Reference><Reference><Citation>Giang NT, van Tong H, Quyet D, Hoan NX, Nghia TH, Nam NM, et al. . Complement protein levels and MBL2 polymorphisms are associated with dengue and disease severity. Sci Rep (2020) 10(1):14923. doi:&#xa0;10.1038/s41598-020-71947-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-71947-2</ArticleId><ArticleId IdType="pmc">PMC7484760</ArticleId><ArticleId IdType="pubmed">32913345</ArticleId></ArticleIdList></Reference><Reference><Citation>Medetalibeyoglu A, Bahat G, Senkal N, Kose M, Avci K, Sayin GY, et al. . Mannose binding lectin gene 2 (rs1800450) missense variant may contribute to development and severity of COVID-19 infection. Infect Genet Evol (2021) 89:104717. doi:&#xa0;10.1016/j.meegid.2021.104717</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2021.104717</ArticleId><ArticleId IdType="pmc">PMC7838598</ArticleId><ArticleId IdType="pubmed">33515713</ArticleId></ArticleIdList></Reference><Reference><Citation>Speletas M, Dadouli K, Syrakouli A, Gatselis N, Germanidis G, Mouchtouri VA, et al. . MBL deficiency-causing b allele (rs1800450) as a risk factor for severe COVID-19. Immunobiology (2021) 226(6):152136. doi:&#xa0;10.1016/j.imbio.2021.152136</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2021.152136</ArticleId><ArticleId IdType="pmc">PMC8462051</ArticleId><ArticleId IdType="pubmed">34628288</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos NP, Ribeiro-Rodrigues EM, Ribeiro-Dos-Santos AK, Pereira R, Gusm&#xe3;o L, Amorim A, et al. . Assessing individual interethnic admixture and population substructure using a 48-insertion-deletion (INSEL) ances-try-informative marker (AIM) panel. Hum Mutat (2010) 31:184&#x2013;90. doi:&#xa0;10.1002/humu.21159</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.21159</ArticleId><ArticleId IdType="pubmed">19953531</ArticleId></ArticleIdList></Reference><Reference><Citation>Stravalaci M, Pagani I, Paraboschi EM, Pedotti M, Doni A, Scavello F, et al. . Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules. Nat Immunol (2022) 23(2):275&#x2013;86. doi:&#xa0;10.1038/s41590-021-01114-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01114-w</ArticleId><ArticleId IdType="pubmed">35102342</ArticleId></ArticleIdList></Reference><Reference><Citation>Asselta R, Paraboschi EM, Stravalaci M, Invernizzi P, Bonfanti P, Biondi A, et al. . Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. mannose-binding lectin genetics in COVID-19. Nat Immunol (2022) 23(6):865&#x2013;7. doi:&#xa0;10.1038/s41590-022-01228-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01228-9</ArticleId><ArticleId IdType="pubmed">35624207</ArticleId></ArticleIdList></Reference><Reference><Citation>Hultstr&#xf6;m M, Frithiof R, Grip J, Lindel&#xf6;f L, Rooijackers O, Pigazzini S, et al. . Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Nat Immunol (2022) 23(6):861&#x2013;4. doi:&#xa0;10.1038/s41590-022-01227-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01227-w</ArticleId><ArticleId IdType="pubmed">35624204</ArticleId></ArticleIdList></Reference><Reference><Citation>Super M, Thiel S, Lu J, Levinsky RJ, Turner MW. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet (1989) 2(8674):1236&#x2013;9. doi:&#xa0;10.1016/s0140-6736(89)91849-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(89)91849-7</ArticleId><ArticleId IdType="pubmed">2573758</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K. Mannose-binding lectin and the balance between immune protection and complication. Expert Rev Anti Infect Ther (2011) 9(12):1179&#x2013;90. doi:&#xa0;10.1586/eri.11.136</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/eri.11.136</ArticleId><ArticleId IdType="pmc">PMC3259613</ArticleId><ArticleId IdType="pubmed">22114968</ArticleId></ArticleIdList></Reference><Reference><Citation>Coomes EA, Haghbayan H. Interleukin-6 in COVID-19: A systematic review and meta-analysis. Rev Med Virol (2020) 30(6):1&#x2013;9. doi:&#xa0;10.1002/rmv.2141</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2141</ArticleId><ArticleId IdType="pmc">PMC7460877</ArticleId><ArticleId IdType="pubmed">32845568</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Shen J, Han Y, Qiao Q, Dai W, He B, et al. . Upregulated IL-6 indicates a poor COVID-19 prognosis: A call for tocilizumab and convalescent plasma treatment. Front Immunol (2021) 12:598799. doi:&#xa0;10.3389/fimmu.2021.598799</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.598799</ArticleId><ArticleId IdType="pmc">PMC7969719</ArticleId><ArticleId IdType="pubmed">33746945</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Chen Y, Zhang Y, Zhang L, Lu X, Chen Z. Mannan-binding lectin directly interacts with toll-like receptor 4 and suppresses lipopolysaccharide-induced inflammatory cytokine secretion from THP-1 cells. Cell Mol Immunol (2011) 8(3):265&#x2013;75. doi:&#xa0;10.1038/cmi.2011.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2011.1</ArticleId><ArticleId IdType="pmc">PMC4012877</ArticleId><ArticleId IdType="pubmed">21383675</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo GD, Lazarini F, Levallois S, Hautefort C, Michel V, Larrous F, et al. . COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci Transl Med (2021) 13(596):eabf8396. doi:&#xa0;10.1126/scitranslmed.abf8396</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf8396</ArticleId><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B, Tang N, Peluso MJ, Iyer NS, Torres L, Donatelli JL, et al. . Characterization and biomarker analyses of post-COVID-19 complications and neurological manifestations. Cells (2021) 10(2):386. doi:&#xa0;10.3390/cells10020386</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020386</ArticleId><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Montefusco L, Ben Nasr M, D'Addio F, Loretelli C, Rossi A, Pastore I, et al. . Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab (2021) 3(6):774&#x2013;85. doi:&#xa0;10.1038/s42255-021-00407-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00407-6</ArticleId><ArticleId IdType="pmc">PMC9931026</ArticleId><ArticleId IdType="pubmed">34035524</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>